Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Renata Ptackova"'
Autor:
Lucie Benesova, Renata Ptackova, Tereza Halkova, Anastasiya Semyakina, Martin Svaton, Ondrej Fiala, Milos Pesek, Marek Minarik
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
Background: Observation of anticancer therapy effect by monitoring of minimal residual disease (MRD) is becoming an important tool in management of non-small cell lung cancer (NSCLC). The approach is based on periodic detection and quantification of
Externí odkaz:
https://doaj.org/article/089f2946a5c14fe4914df4dad2fe7b16
Autor:
ONDREJ FIALA, JAN BAXA, MARTIN SVATON, LUCIE BENESOVA, RENATA PTACKOVA, TEREZA HALKOVA, MAREK MINARIK, PETR HOSEK, MARCELA BURESOVA, JINDRICH FINEK, JIRI FERDA, MILOS PESEK
Publikováno v:
Cancer Genomics - Proteomics. 19:270-281
Autor:
Marcela Buresova, Lucie Benesova, Marek Minarik, Renata Ptackova, Tereza Halkova, Petr Hosek, Jan Baxa, Milos Pesek, Martin Svaton, Ondrej Fiala
Publikováno v:
Journal of Cancer. 14(1)
Autor:
Marek Minarik, Filip Pazdirek, Miroslav Ryska, Milan Blaha, Lucie Benesova, Anastasiya Semyakina, Jiří Pudil, Jiří Hoch, J. Simsa, Kateřina Menclová, Tereza Halkova, Renata Ptackova, Miroslav Levý
Publikováno v:
World Journal of Gastroenterology
BACKGROUND One of the most notable applications for circulating tumor DNA (ctDNA) detection in peripheral blood of patients with metastatic colorectal cancer (mCRC) is a long-term postoperative follow-up. Sometimes referred to as a “liquid (re)biop
Autor:
Ondrej, Fiala, Jan, Baxa, Martin, Svaton, Lucie, Benesova, Renata, Ptackova, Tereza, Halkova, Marek, Minarik, Petr, Hosek, Marcela, Buresova, Jindrich, Finek, Jiri, Ferda, Milos, Pesek
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: Circulating tumour DNA (ctDNA) represents an emerging biomarker in non-small cell lung cancer (NSCLC). We focused on the combination of ctDNA and positron emission tomography/computed tomography (PET/CT) in the follow-up monitoring of
Autor:
Miloš Pešek, Renata Ptackova, Martin Svatoň, Benesova Lucie, Ondrej Fiala, Masrek Minarik, Barbora Belsanova
Publikováno v:
Lung cancer.
Introduction: The efficacy of anti-angiogenic lung cancer therapy is relying on imaging techniques. Monitoring monitoring of minimal residual disease by detection and quantification of ctDNA opened a new ability to predict therapy response. This stud
Autor:
Anton Škríba, Abdullah M. S. Al-Hatmi, Annelies Verbon, Vladimír Havlíček, Tokameh Mahmoudi, Elisa De Crignis, Mohammad Javad Najafzadeh, Raquel Crespo, Tsung Wai Kan, Renata Ptackova, Robert-Jan Palstra, Miroslav Sulc, Enrico Ne, Joyce Kang, Michael Roling, Casper Rokx, Elizabeth LeMasters, Peter D. Katsikis, Wilfred F. J. van IJcken, Joyce H.G. Lebbink, Sybren de Hoog, Pritha Biswas, Mateusz Stoszko, Yvonne M. Mueller, Alessia Bertoldi
Publikováno v:
Science Advances, 6
Science Advances, 6, 33
Science Advances
Science advances, 6(33):eaha6617. American Association for the Advancement of Science
Science Advances, 6, 33
Science Advances
Science advances, 6(33):eaha6617. American Association for the Advancement of Science
Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency.
A leading pharmacological strategy toward HIV cure requires “shock” or activation of HIV gene expression in latently
A leading pharmacological strategy toward HIV cure requires “shock” or activation of HIV gene expression in latently
Autor:
Pritha Biswas, Mateusz Stoszko, Yvonne M. Mueller, Abdullah M. S. Al-Hatmi, Wilfred F. J. van IJcken, Alessia Bertoldi, Robert-Jan Palstra, Miroslav Sulc, Joyce H.G. Lebbink, Elisa De Crignis, Sybren de Hoog, Raquel Crespo, Enrico Ne, Joyce Kang, Renata Ptackova, Anton Škríba, Peter D. Katsikis, Mohammad Javad Najafzadeh, Tokameh Mahmoudi, Annelies Verbon, Tsung Wai Kan, Vladimír Havlíček, Casper Rokx, Michael Roling
A leading pharmacological strategy towards HIV cure requires “shock” or activation of HIV gene expression in latently infected cells with Latency Reversal Agents (LRAs) followed by their subsequent clearance. In a screen for novel LRAs we used fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0be8c0054b95ac123f197d740eab2420
https://doi.org/10.1101/848929
https://doi.org/10.1101/848929
Autor:
Jiri Pudil, Marek Minarik, Lubos Petruzelka, Jaromir Simsa, Tereza Halkova, Miroslav Ryska, Lucie Benesova, Miroslav Levy, Jiri Hoch, Barbora Belsanova, Renata Ptackova, Filip Pazdirek
Publikováno v:
Cancer Research. 80:724-724
Introduction: Liquid biopsy based on detection of circulating tumor DNA (circulating-tumor DNA, ctDNA) is finding new applications in clinical management of solid cancers. From the initial use as an alternative to classical tissue biopsy for investig
Autor:
Marek Minarik, Renata Ptackova, Lucie Benesova, Martin Svaton, Anastasiya Semyakina, Tereza Halkova, Barbora Belsanova, Miloš Pešek, Ondrej Fiala
Publikováno v:
Clinical Cancer Research. 26:A30-A30
Introduction: Liquid biopsy methodology has long been utilized in management of patients with advanced lung cancer. The approach found its use in testing for a presence of somatic mutations of EGFR gene in circulating tumor DNA (ctDNA) to predict ant